|
|
Volumn 4, Issue 1, 1998, Pages 11-12
|
|
Ethical considerations of clinical trials to prevent vertical transmission of HIV in developing countries
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLINICAL TRIAL;
DEVELOPING COUNTRY;
ETHICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
NOTE;
PRIORITY JOURNAL;
PROPHYLAXIS;
VERTICAL TRANSMISSION;
ACQUIRED IMMUNODEFICIENCY SYNDROME--PREVENTION AND CONTROL;
AUTONOMY;
AZT;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL APPROACH/SOURCE;
CLINICAL RESEARCH;
CLINICAL TRIALS;
COMPETENCE;
CRITIQUE;
DEVELOPING COUNTRIES;
DISEASES;
DRUGS--THERAPEUTIC USE;
ETHICS;
HIV INFECTIONS--PREVENTION AND CONTROL;
HUMAN VOLUNTEERS;
INFORMED CONSENT;
PREGNANT WOMEN;
RESEARCH METHODOLOGY;
RESEARCH SUBJECTS;
TREATMENT;
VERTICAL TRANSMISSION;
VIRAL DISEASES;
ANTI-HIV AGENTS;
BIOETHICS;
CLINICAL TRIALS;
DEVELOPING COUNTRIES;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
PERSONAL AUTONOMY;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANT WOMEN;
RESEARCH SUBJECTS;
ZIDOVUDINE;
|
|
EID: 0031952910
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0198-011 Document Type: Note |
|
Times cited : (4)
|
|
References (5)
|
